ERVW-1 and infection: Env IgG3 antibodies that mediated antibody-dependent cellular cytotoxicity (ADCC), or antibody-dependent cellular phagocytosis (ADCP), correlated with a decreased risk of infection in the RV144 trial; however, these responses decreased more than 10-fold in the first 6 months after the vaccination [62,72].